- Indoxyl sulfate, homocysteine, and antioxidant capacities in patients at different stages of chronic kidney disease
-
Chen CH, Huang SC, Yeh EL, Lin PC, Tsai SF, Huang YC
- KMID: 2532096
- Nutr Res Pract.
- 2022 Aug;16(4):464-475.
- doi: 10.4162/nrp.2022.16.4.464
BACKGROUND/OBJECTIVES: Increased levels of uremic toxins and decreased antioxidant capacity have a significant impact on the progression of chronic kidney disease (CKD). However, it remains unclear whether they interact with... -
- CITED
-
- Close
- SHARE
-
- Close
- Multislice CT Scans in Patients on Extracorporeal Membrane Oxygenation: Emphasis on Hemodynamic Changes and Imaging Pitfalls
-
Liu KL, Wang YF, Chang YC, Huang SC, Chen SJ, Tsang YM, Chang CC
- KMID: 2078641
- Korean J Radiol.
- 2014 Jun;15(3):322-329.
- doi: 10.3348/kjr.2014.15.3.322
This pictorial review provides the principles of extracorporeal membrane oxygenation (ECMO) support and associated CT imaging features with emphasis on the hemodynamic changes and possible imaging pitfalls encountered. It is... -
- CITED
-
- Close
- SHARE
-
- Close
- Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: Challenges and perspectives
-
Huang SC, Liu CJ
- KMID: 2541408
- Clin Mol Hepatol.
- 2023 Apr;29(2):320-331.
- doi: 10.3350/cmh.2022.0422
The prevalence of metabolic dysfunction-associated fatty liver disease (MAFLD) has increased among the general population and chronic hepatitis B (CHB) patients worldwide. Although fatty liver disease is a well-known risk... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk of Hepatitis B Virus (HBV) Reactivation in HBsAg-Negative, Anti-HBc-Negative Patients Receiving Rituximab for Autoimmune Diseases in HBV Endemic Areas
-
Lan TY, Lin YC, Tseng TC, Yang HC, Kao JH, Cheng CF, Lee TJ, Huang SC, Lu CH, Li KJ, Hsieh SC
- KMID: 2540417
- Gut Liver.
- 2023 Mar;17(2):288-298.
- doi: 10.5009/gnl210551
Background/Aims: Rituximab is known to be associated with high hepatitis B virus (HBV) reactivation rate in patients with resolved HBV infection and hematologic malignancy. However, data regarding HBV reactivation (HBVr) in... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical and Histologic Features of Patients with Biopsy-Proven Metabolic Dysfunction-Associated Fatty Liver Disease
-
Huang SC, Su HJ, Kao JH, Tseng TC, Yang HC, Su TH, Chen PJ, Liu CJ
- KMID: 2515849
- Gut Liver.
- 2021 May;15(3):451-458.
- doi: 10.5009/gnl20218
Background/Aims: Fatty liver disease is defined as a cluster of diseases with heterogeneous etiologies, and its definition continues to evolve. The novel conceptional criteria for metabolic dysfunction-associated fatty liver disease... -
- CITED
-
- Close
- SHARE
-
- Close
- Direct comparison of biopsy techniques for hepatic malignancies
-
Huang SC, Liang JD, Hsu SJ, Hong TC, Yang HC, Kao JH
- KMID: 2514772
- Clin Mol Hepatol.
- 2021 Apr;27(2):305-312.
- doi: 10.3350/cmh.2020.0301
Background/Aims: The core needle biopsy (CNB), fine needle aspiration cytology (FNAC) and touch imprint cytology (TIC) are commonly used tools for the diagnosis of hepatic malignancies. However, little is known... -
- CITED
-
- Close
- SHARE
-
- Close
- 2022 Taiwan clinical multicenter expert consensus and recommendations for thyroid radiofrequency ablation
-
Lin WC, Chen WC, Wang PW, Chan YC, Chang YH, Chen HS, Chen ST, Chen WC, Cheng KL, Chi SY, Chiang PL, Chou CK, Chou FF, Huang SC, Liu FH, Luo SD, Tseng FY, Wang CY, Wang WH, Wu MH
- KMID: 2543373
- Ultrasonography.
- 2023 Jul;42(3):357-375.
- doi: 10.14366/usg.22126
Radiofrequency ablation (RFA) is a minimally invasive management strategy that has been widely applied for benign and recurrent malignant thyroid lesions as an alternative to surgery in Taiwan. Members of... -
- CITED
-
- Close
- SHARE
-
- Close
